(ACGL) Arch Capital - Overview
Exchange: NASDAQ •
Country: Bermuda •
Currency: USD •
Type: Common Stock •
ISIN: BMG0450A1053
Stock: Insurance, Reinsurance, Mortgage
Total Rating 50
Risk 70
Buy Signal -0.01
| Risk 5d forecast | |
|---|---|
| Volatility | 23.3% |
| Relative Tail Risk | -2.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.09 |
| Alpha | -4.21 |
| Character TTM | |
|---|---|
| Beta | 0.127 |
| Beta Downside | 0.328 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.43% |
| CAGR/Max DD | 0.63 |
EPS (Earnings per Share)
Revenue
Description: ACGL Arch Capital March 04, 2026
Arch Capital Group Ltd. (ACGL) is a Bermuda-based company providing insurance, reinsurance, and mortgage insurance products globally.
The company operates through three core segments. The Insurance segment offers diverse commercial and specialty lines, including commercial multiperil and workers compensation. Property & Casualty Insurance is a mature industry, often characterized by underwriting cycles.
The Reinsurance segment provides coverage for various risks, such as property catastrophe and casualty. Reinsurance companies help primary insurers manage risk exposure and capital.
The Mortgage segment specializes in U.S. primary mortgage insurance, predominantly for government-sponsored enterprise loans, and international mortgage insurance. Mortgage insurance protects lenders against borrower default.
ACGL distributes its products through independent retail and wholesale brokers. Further research on ValueRay can provide deeper insights into ACGLs financial performance and market position.
Headlines to watch out for
- Catastrophe losses impact property and casualty reinsurance segment earnings
- Mortgage insurance volume sensitive to interest rate fluctuations
- Investment portfolio performance affects overall profitability
- Regulatory changes in insurance markets create compliance costs
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 4.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -0.20 > 1.0 |
| NWC/Revenue: 7.75% < 20% (prev -92.78%; Δ 100.5% < -1%) |
| CFO/TA 0.09 > 3% & CFO 6.17b > Net Income 4.40b |
| Net Debt (1.74b) to EBITDA (5.35b): 0.32 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (376.1m) vs 12m ago -1.49% < -2% |
| Gross Margin: 37.16% > 18% (prev 0.37%; Δ 3.68k% > 0.5%) |
| Asset Turnover: 28.89% > 50% (prev 24.60%; Δ 4.29% > 0%) |
| Interest Coverage Ratio: 34.86 > 6 (EBITDA TTM 5.35b / Interest Expense TTM 148.0m) |
Altman Z'' 2.63
| A: 0.02 (Total Current Assets 8.99b - Total Current Liabilities 7.44b) / Total Assets 67.06b |
| B: 0.40 (Retained Earnings 27.05b / Total Assets 67.06b) |
| C: 0.07 (EBIT TTM 5.16b / Avg Total Assets 68.98b) |
| D: 0.63 (Book Value of Equity 27.05b / Total Liabilities 42.85b) |
| Altman-Z'' Score: 2.63 = A |
Beneish M
| DSRI: 0.43 (Receivables 7.99b/16.40b, Revenue 19.93b/17.44b) |
| GMI: 0.99 (GM 37.16% / 36.97%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.14 (Revenue 19.93b / 17.44b) |
| TATA: -0.03 (NI 4.40b - CFO 6.17b) / TA 67.06b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ACGL shares?
As of March 18, 2026, the stock is trading at USD 94.40 with a total of 1,315,185 shares traded.
Over the past week, the price has changed by -1.86%, over one month by -4.53%, over three months by -1.55% and over the past year by -0.92%.
Over the past week, the price has changed by -1.86%, over one month by -4.53%, over three months by -1.55% and over the past year by -0.92%.
Is ACGL a buy, sell or hold?
Arch Capital has received a consensus analysts rating of 4.14.
Therefore, it is recommended to buy ACGL.
- StrongBuy: 6
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ACGL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 109.3 | 15.8% |
| Analysts Target Price | 109.3 | 15.8% |
ACGL Fundamental Data Overview March 16, 2026
P/E Trailing = 8.0578
P/E Forward = 9.8912
P/S = 1.7008
P/B = 1.4227
P/EG = 1.0547
Revenue TTM = 19.93b USD
EBIT TTM = 5.16b USD
EBITDA TTM = 5.35b USD
Long Term Debt = 2.73b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.73b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.74b USD (from netDebt column, last quarter)
Enterprise Value = 25.08b USD (33.89b + Debt 2.73b - CCE 11.54b)
Interest Coverage Ratio = 34.86 (Ebit TTM 5.16b / Interest Expense TTM 148.0m)
EV/FCF = 4.09x (Enterprise Value 25.08b / FCF TTM 6.13b)
FCF Yield = 24.43% (FCF TTM 6.13b / Enterprise Value 25.08b)
FCF Margin = 30.75% (FCF TTM 6.13b / Revenue TTM 19.93b)
Net Margin = 22.07% (Net Income TTM 4.40b / Revenue TTM 19.93b)
Gross Margin = 37.16% ((Revenue TTM 19.93b - Cost of Revenue TTM 12.52b) / Revenue TTM)
Gross Margin QoQ = 43.22% (prev 40.00%)
Tobins Q-Ratio = 0.37 (Enterprise Value 25.08b / Total Assets 67.06b)
Interest Expense / Debt = 1.39% (Interest Expense 38.0m / Debt 2.73b)
Taxrate = 14.50% (210.0m / 1.45b)
NOPAT = 4.41b (EBIT 5.16b * (1 - 14.50%))
Current Ratio = 1.21 (Total Current Assets 8.99b / Total Current Liabilities 7.44b)
Debt / Equity = 0.11 (Debt 2.73b / totalStockholderEquity, last quarter 24.21b)
Debt / EBITDA = 0.32 (Net Debt 1.74b / EBITDA 5.35b)
Debt / FCF = 0.28 (Net Debt 1.74b / FCF TTM 6.13b)
Total Stockholder Equity = 23.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.38% (Net Income 4.40b / Total Assets 67.06b)
RoE = 19.02% (Net Income TTM 4.40b / Total Stockholder Equity 23.13b)
RoCE = 19.95% (EBIT 5.16b / Capital Employed (Equity 23.13b + L.T.Debt 2.73b))
RoIC = 17.62% (NOPAT 4.41b / Invested Capital 25.03b)
WACC = 5.99% (E(33.89b)/V(36.62b) * Re(6.38%) + D(2.73b)/V(36.62b) * Rd(1.39%) * (1-Tc(0.15)))
Discount Rate = 6.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.49%
[DCF] Terminal Value 88.10% ; FCFF base≈6.33b ; Y1≈7.80b ; Y5≈13.29b
[DCF] Fair Price = 1.05k (EV 375.08b - Net Debt 1.74b = Equity 373.34b / Shares 355.8m; r=5.99% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 59.63 | EPS CAGR: 30.44% | SUE: 1.38 | # QB: 5
Revenue Correlation: 96.85 | Revenue CAGR: 31.27% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.49 | Chg7d=-0.002 | Chg30d=-0.034 | Revisions Net=-10 | Analysts=18
EPS current Year (2026-12-31): EPS=9.37 | Chg7d=+0.000 | Chg30d=+0.008 | Revisions Net=-2 | Growth EPS=-4.7% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=10.11 | Chg7d=+0.009 | Chg30d=-0.061 | Revisions Net=-5 | Growth EPS=+7.9% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: -0.83 (1 Up / 11 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.5% (Discount Rate 7.9% - Earnings Yield 12.4%)
[Growth] Growth Spread = +5.5% (Analyst 1.1% - Implied -4.5%)
P/E Forward = 9.8912
P/S = 1.7008
P/B = 1.4227
P/EG = 1.0547
Revenue TTM = 19.93b USD
EBIT TTM = 5.16b USD
EBITDA TTM = 5.35b USD
Long Term Debt = 2.73b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.73b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.74b USD (from netDebt column, last quarter)
Enterprise Value = 25.08b USD (33.89b + Debt 2.73b - CCE 11.54b)
Interest Coverage Ratio = 34.86 (Ebit TTM 5.16b / Interest Expense TTM 148.0m)
EV/FCF = 4.09x (Enterprise Value 25.08b / FCF TTM 6.13b)
FCF Yield = 24.43% (FCF TTM 6.13b / Enterprise Value 25.08b)
FCF Margin = 30.75% (FCF TTM 6.13b / Revenue TTM 19.93b)
Net Margin = 22.07% (Net Income TTM 4.40b / Revenue TTM 19.93b)
Gross Margin = 37.16% ((Revenue TTM 19.93b - Cost of Revenue TTM 12.52b) / Revenue TTM)
Gross Margin QoQ = 43.22% (prev 40.00%)
Tobins Q-Ratio = 0.37 (Enterprise Value 25.08b / Total Assets 67.06b)
Interest Expense / Debt = 1.39% (Interest Expense 38.0m / Debt 2.73b)
Taxrate = 14.50% (210.0m / 1.45b)
NOPAT = 4.41b (EBIT 5.16b * (1 - 14.50%))
Current Ratio = 1.21 (Total Current Assets 8.99b / Total Current Liabilities 7.44b)
Debt / Equity = 0.11 (Debt 2.73b / totalStockholderEquity, last quarter 24.21b)
Debt / EBITDA = 0.32 (Net Debt 1.74b / EBITDA 5.35b)
Debt / FCF = 0.28 (Net Debt 1.74b / FCF TTM 6.13b)
Total Stockholder Equity = 23.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.38% (Net Income 4.40b / Total Assets 67.06b)
RoE = 19.02% (Net Income TTM 4.40b / Total Stockholder Equity 23.13b)
RoCE = 19.95% (EBIT 5.16b / Capital Employed (Equity 23.13b + L.T.Debt 2.73b))
RoIC = 17.62% (NOPAT 4.41b / Invested Capital 25.03b)
WACC = 5.99% (E(33.89b)/V(36.62b) * Re(6.38%) + D(2.73b)/V(36.62b) * Rd(1.39%) * (1-Tc(0.15)))
Discount Rate = 6.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.49%
[DCF] Terminal Value 88.10% ; FCFF base≈6.33b ; Y1≈7.80b ; Y5≈13.29b
[DCF] Fair Price = 1.05k (EV 375.08b - Net Debt 1.74b = Equity 373.34b / Shares 355.8m; r=5.99% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 59.63 | EPS CAGR: 30.44% | SUE: 1.38 | # QB: 5
Revenue Correlation: 96.85 | Revenue CAGR: 31.27% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.49 | Chg7d=-0.002 | Chg30d=-0.034 | Revisions Net=-10 | Analysts=18
EPS current Year (2026-12-31): EPS=9.37 | Chg7d=+0.000 | Chg30d=+0.008 | Revisions Net=-2 | Growth EPS=-4.7% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=10.11 | Chg7d=+0.009 | Chg30d=-0.061 | Revisions Net=-5 | Growth EPS=+7.9% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: -0.83 (1 Up / 11 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.5% (Discount Rate 7.9% - Earnings Yield 12.4%)
[Growth] Growth Spread = +5.5% (Analyst 1.1% - Implied -4.5%)